Qiagen Initiating First Tranche of Share Buyback Program; Repurchasing $10M of Shares
September 24, 2012
Qiagen Initiating First Tranche of Share Buyback Program; Repurchasing $10M of Shares
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology
May 20, 2013 / Pharmacogenomics Reporter - Qiagen to Distribute Sygnis Pharma Amplification Buffer Under Licensing Pact
May 16, 2013 / PCR Insider - Sygnis Licenses Amplification Buffer to Qiagen
May 16, 2013 / GenomeWeb Daily News - Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter - Transgenomic to Develop RAS Mutation Test with Amgen for Metastatic CRC Patients
May 15, 2013 / Pharmacogenomics Reporter